Bevacizumab vs Memantine

## Bevacizumab vs Memantine: Overview

This comparison examines the pharmacological differences between **Bevacizumab** and **Memantine**.

## Mechanism of Action

**Memantine**: Non-competitive NMDA receptor antagonist.

## Pharmacokinetics

**Half-life**: Bevacizumab — N/A; Memantine — 60-80 hours.

## Chemical Properties

**Molecular Formula**: Bevacizumab — N/A; Memantine — C12H21N.

**Molecular Weight**: Bevacizumab — N/A; Memantine — 179.3080 g/mol.

**Type**: Bevacizumab — Antibody; Memantine — Small molecule.